Skip to main content

Table 2 Demographic and clinical characteristics*

From: Echium oil is not protective against weight loss in head and neck cancer patients undergoing curative radio(chemo)therapy: a randomised-controlled trial

 

Intervention group (I) N = 43

Control group (C) N = 42

Demographic characteristics

Median (range)

 

Age

61.0 (30 – 81)

60.5 (35–79)

Gender

n (%)

 

Male

36 (83.7)

35 (83.3)

Female

7 (16.3)

7 (16.7)

ECOG PS ≤1

34 (79.1)

38 (90.5)

Social status

  

Married/living together

31 (72.1)

34 (81.0)

Profession

  

Labourer

18 (41.9)

17 (40.5)

Employee

20 (46.5)

19 (45.2)

Self-employed

5 (11.6)

5 (11.9)

 

Median (Q1, Q3)

 

Alcohol consumption (U/day)

4.0 (1.0, 8.0)

3.0 (1.0, 6.3)

Tobacco consumption (PY)

25.5 (8.6, 40.3)

35.0 (17.8, 50.0)

Clinical characteristics

n (%)

 

Tumour location

  

Oral cavity

11 (25.6)

7 (16.7)

Oropharynx

17 (39.5)

17 (40.5)

Hypopharynx

7 (16.3)

4 (9.5)

Nasopharynx

2 (4.7)

2 (4.8)

Supraglottis

2 (4.7)

7 (16.7)

Glottis

2 (4.7)

2 (4.8)

Occult primary

2 (4.7)

3 (7.1)

Tumour stage

  

Early stage (I-II)

6 (14.0)

8 (19.0)

Late stage (III-IVb)

37 (86.0)

34 (81.0)

Therapy initiation

  

Neoadjuvant chemotherapy + radiochemotherapy

2 (4.7)

4 (9.5)

Primary radiotherapy

  

 Alone

7 (16.3)

8 (19.0)

 With chemotherapy

22 (51.2)

18 (42.9)

 With biotherapy

0 (0.0)

2 (4.8)

Adjuvant radiotherapy

  

 Alone

5 (11.6)

3 (7.1)

 With chemotherapy

7 (16.3)

7 (16.7)

 With biotherapy

0 (0.0)

0 (0.0)

Nutritional characteristics

Median (Q1, Q3)

 

6-months weight loss (%)

2.5 (6.8, −1.5)

2.2 (5.4, 2.4)

BMI (kg/m2)

22.80 (20.50, 28.70)

24.25 (21.8, 27.2)

PG-SGA score

10.0 (5.0, 15.0)

8.5 (6.8, 13.0)

Caloric intake (kcal/day)

1784 (1449, 2284)

1759 (1531, 2198)

  1. *Both groups did not significantly differ in demographic, nor clinical, nor nutritional characteristics at P < 0.05.